YIELD10 BIOSCI Balance Sheet - Quarterly (NASDAQ:YTEN)

Add to My Stocks
$1.68 $0.03 (1.75%) YTEN stock closing price Apr 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at YIELD10 BIOSCI balance sheet. Financial strength can be guaged by performing YIELD10 BIOSCI stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. YIELD10 BIOSCI balance sheet as at the end of 2017 Q4 indicates an asset turnover ratio of 0.04 and debt to equity ratio of 0.07. Also check YIELD10 BIOSCI revenue and YIELD10 BIOSCI operating cash flow for the same period.

View and download YIELD10 BIOSCI quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Cash14.48M2.95M3.01M4.87M7.3M9.78M3.7M5.76M12.26M17.89M
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets-------1.38M1.66M1.44M
Total Current Assets
14.91M3.48M3.9M5.65M7.86M10.58M5.66M8.09M14.85M20.42M
Property Plant & Equipment3.02M---3.21M---7.25M-
Accumulated Depreciation1.48M---1.47M---6.34M-
Net Property Plant & Equipment
1.53M1.58M1.63M1.68M1.73M1.79M2.57M1.35M--
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets-----1.14M1.14M1.14M1.33M-
Total Assets
16.88M5.57M6.06M8.49M10.74M13.52M9.38M10.6M17.08M22.12M
Notes Payable----------
Accounts Payable------1.46M---
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses2.29M1.93M2.68M2.53M2.7M2.74M1.7M2.65M3.51M3.59M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
2.37M1.98M2.75M2.58M2.75M2.97M4.05M3.1M3.91M4.19M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases1M1.03M1.06M1.1M1.13M-----
Other Long-Term Liabilities-----1.96M1.19M---
Total Liabilities
3.38M3.02M3.82M3.93M4.37M4.94M5.24M3.42M4.06M4.34M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus355.43M342.79M340.47M339.81M339.52M339.8M339.39M339.22M338.58M337.41M
Retained Earnings-342.75M-340.2M-338.17M-335.44M-333.35M-331.42M-335.44M-332.25M-325.75M-319.83M
Treasury Stock----------
Other Liabilities-0.08M-0.08M-0.08M-0.08M-0.08M-0.08M-0.07M-0.07M-0.07M-0.07M
Shareholders Equity13.5M2.54M2.24M4.56M6.36M8.57M4.14M7.17M13.02M17.77M
Total Liabilities & Shareholders Equity16.88M5.57M6.06M8.49M10.74M13.52M9.38M10.6M17.08M22.12M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Honeywell financial analysis

Apart from balance sheet items, an investor would do well to keep track of the YIELD10 BIOSCI stock price by looking at YIELD10 BIOSCI historical stock prices. One can compare PE with industry average by looking at the YIELD10 BIOSCI PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like YIELD10 BIOSCI owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for YTEN stock as of 2017 Q4 is $16.88M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. YTEN stock had total liabilities of $3.38M for the quarter 2017 Q4.

YIELD10 BIOSCI Balance Sheet - Key Ratios

Current ratio
6.29
Debt to equity ratio
0.07
Asset turnover ratio
0.04
Receivables turnover
4.08
Price to book ratio
1.16